Organon & Co. Common Stock OGN 深 沪
已收盘 09-18 16:00:00 美东时间
19.97
-0.580
-2.82%
华盛通- 最 高20.58
- 今 开20.51
- 成交量 386.31万股
- 最 低 19.42
- 昨 收 20.55
- 总市值 51.12亿
- 52周最高 23.10
- 市盈率 静 5.00
- 换手率 1.51%
- 52周最低 9.995
- 委 比 -85.19%
- 总股本 2.56亿
- 历史最高 36.675
- 量 比 3.25
- 振 幅 5.64%
- 历史最低 9.995
- 每 手 1
- 风险率 3.41%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多快讯 | Roivant Sciences股价盘前上涨3.3％，因Organon同意以高达12亿美元收购该公司的部门
Roivant Sciences Shares up 3.3% Premarket After Organon Agrees to Buy Co's Unit...
09-18 20:32
Roivant Sciences Subsidiary Acquired for $1.2 Billion
Roivant Sciences ( ($ROIV) ) just unveiled an update. Organon has announced pla...
09-18 19:57
Organon to acquire Dermavant for $1.2 billion
Organon (NYSE:OGN) said it will acquire Dermavant, which is a Roivant (ROIV) for $1.2 billion. The consideration has an upfront payment of $175 million and a $75 million milestone payment upon regulat...
09-18 19:44
快讯 | Organon和FDA正在审查Vtama乳膏的SNDA作为治疗成人和2岁及以上儿童的AD的潜在治疗方法，PDUFA行动计划将在第四季度实施
Organon & Co-FDA Reviewing Snda for Vtama Cream as Potential Treatment for ...
09-18 19:33
快讯 | Organon & Co：2025年微弱地对调整后息税折旧摊销前息税折旧摊销利润产生折损的交易，到2026年开始对利润产生增值
Organon & Co: Deal to Be Modestly Dilutive to Adj Ebitda in 2025, Turning A...
09-18 19:31
Teva Announces $80M Settlement To Baltimore: City Continues Opioid Litigation Against Other Companies
Baltimore secures an $80 million settlement with Teva Pharmaceuticals in its opioid crisis litigation. Funds will be allocated to education, recovery centers, and outreach initiatives.
09-11 02:09
Broadcom Shares Are Trading Lower Today: What You Need To Know
Shares of Broadcom Inc. (NASDAQ: AVGO) are trading lower Friday, despite the company reporting robust third-quarter earnings that exceeded market expectations. Here's what you need to know.
09-07 03:24
Organon downgraded, Amneal upgraded as J.P. Morgan reviews specialty pharma
J.P. Morgan reevaluated its coverage of the North American specialty pharma space on Friday, downgrading the generic drugmaker Organon (NYSE:OGN) and upgrading its smaller peer Amneal Pharmaceuticals ...
09-06 20:39
JP Morgan Downgrades Organon to Underweight, Raises Price Target to $20
JP Morgan analyst Chris Schott downgrades Organon (NYSE:OGN) from Neutral to Underweight and raises the price target from $18 to $20.
09-06 20:18
